Nahdi Medical Co. reported a net profit of SAR 662.9 million for the first nine months of 2024, an 8% growth from SAR 722.1 million in the year-earlier period.
Item | 9m 2023 | 9m 2024 | Change |
---|---|---|---|
Revenues | 6,499.42 | 7,083.40 | 9.0 % |
Gross Income | 2,668.50 | 2,650.50 | (0.7 %) |
Operating Income | 775.90 | 680.90 | (12.2 %) |
Net Income | 722.10 | 662.90 | (8.2 %) |
Average Shares | 130.00 | 130.00 | - |
EPS (Riyals) | 5.55 | 5.10 | (8.2 %) |
Gross profit declined by 18 million year-on-year (YoY) to SAR 2.65 billion due to the sustained investment to support sales growth.
Operating expenses (OpEx) increased by SAR 78.6 million due to the company’s continuous investments in various strategic initiatives including new openings, healthcare performance, UAE expansions and digitalization. Despite the increase, the OpEx as a percentage of revenue improved by 1.3% YoY to 28.1%.
Consequently, operating profit reached SAR 681 million, a decrease of 12.3% YoY. Moreover, there was a net increase of SAR 4.3 million in the items below operating profit, mainly in financial charges and lease liability interest to support the revenue growth.
Zakat charges decreased by SAR 40.2 million mainly due to a one-time written-back provisions of SAR 32.7 million, resulting from the Zakat settlements for most of the previous years.
Revenue grew 9% YoY to SAR 7.08 billion, driven by a strong performance in the retail business. Moreover, the healthcare and UAE businesses recorded growth of 104.7% and 158.4% respectively.
Item | Q3 2023 | Q3 2024 | Change |
---|---|---|---|
Revenues | 2,162.90 | 2,353.30 | 8.8 % |
Gross Income | 878.90 | 851.00 | (3.2 %) |
Operating Income | 229.80 | 175.80 | (23.5 %) |
Net Income | 212.81 | 182.20 | (14.4 %) |
Average Shares | 130.00 | 130.00 | - |
EPS (Riyals) | 1.64 | 1.40 | (14.4 %) |
Item | Q2 2024 | Q3 2024 | Change |
---|---|---|---|
Revenues | 2,472.66 | 2,353.30 | (4.8 %) |
Gross Income | 938.68 | 851.00 | (9.3 %) |
Operating Income | 273.40 | 175.80 | (35.7 %) |
Net Income | 247.74 | 182.20 | (26.5 %) |
Average Shares | 130.00 | 130.00 | - |
EPS (Riyals) | 1.91 | 1.40 | (26.5 %) |
Q3 2024 net profit stood at SAR 182.2 million, a decline of 14.4% YoY from SAR 212.8 million.
Q3 revenue grew 8.8% YoY to SAR 2.35 billion, primarily driven by the strong performance in the retail business. Moreover, healthcare and UAE businesses continued their revenue growth delivering 96.5% and 125.9%, respectively.
On a sequential basis, net earnings decreased by 26.5% from SAR 247.7 million.
Total shareholders’ equity (no minority equity) stood at SAR 2.40 billion by Sept. 30, 2024, compared to SAR 2.27 billion a year earlier.
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}